Markers of eosinophilic inflammation and risk prediction in patients with coronary artery disease.

PubWeight™: 0.85‹?›

🔗 View Article (PMID 16620281)

Published in Eur J Clin Invest on April 01, 2006

Authors

C Falcone1, P Minoretti, A D'Angelo, M P Buzzi, E Coen, E Emanuele, A Aldeghi, V Olivieri, D Geroldi

Author Affiliations

1: Department of Hematological, Pneumological and Cardiovascular Sciences, University of Pavia, Italy.

Articles by these authors

Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy. Lancet (1996) 6.58

An epigenetic mutation responsible for natural variation in floral symmetry. Nature (1999) 5.32

Complementary floral homeotic phenotypes result from opposite orientations of a transposon at the plena locus of Antirrhinum. Cell (1993) 4.47

Association studies of genetic polymorphisms and complex disease. Lancet (2000) 4.37

Inflorescence commitment and architecture in Arabidopsis. Science (1997) 4.26

Origin of floral asymmetry in Antirrhinum. Nature (1996) 3.74

A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS). J Thromb Haemost (2005) 3.47

The TCP domain: a motif found in proteins regulating plant growth and development. Plant J (1999) 3.44

Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon. J Clin Invest (1987) 3.29

Adjunctive systemic hyperbaric oxygen therapy in treatment of severe prevalently ischemic diabetic foot ulcer. A randomized study. Diabetes Care (1996) 2.80

Control of organ asymmetry in flowers of Antirrhinum. Cell (1999) 2.74

Control of inflorescence architecture in Antirrhinum. Nature (1996) 2.56

Dynamics of concerted evolution of ribosomal DNA and histone gene families in the melanogaster species subgroup of Drosophila. J Mol Biol (1982) 2.54

Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian Registry. Am J Med (1996) 2.51

Enoxaparin plus compression stockings compared with compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery. N Engl J Med (1998) 2.03

Studies on the mode of action of nalidixic acid. Eur J Biochem (1972) 2.00

Prevalence of antibodies to lymphadenopathy-associated retrovirus in African patients with AIDS. Science (1984) 1.95

The expression of D-cyclin genes defines distinct developmental zones in snapdragon apical meristems and is locally regulated by the Cycloidea gene. Plant Physiol (2000) 1.92

Activated platelets present high mobility group box 1 to neutrophils, inducing autophagy and promoting the extrusion of neutrophil extracellular traps. J Thromb Haemost (2014) 1.91

Antithrombin III (ATIII) replacement therapy in patients with sepsis and/or postsurgical complications: a controlled double-blind, randomized, multicenter study. Intensive Care Med (1998) 1.90

Effects of dietary protein and phosphorus restriction on the progression of early renal failure. Kidney Int (1982) 1.83

Prevalence of moderate hyperhomocysteinemia in patients with early-onset venous and arterial occlusive disease. Ann Intern Med (1995) 1.70

Vitreomacular traction syndrome: a comparison of treatment with intravitreal plasmin enzyme vs spontaneous vitreous separation without treatment. Eye (Lond) (2012) 1.60

Prevention of colonic fibrosis by Boswellia and Scutellaria extracts in rats with colitis induced by 2,4,5-trinitrobenzene sulphonic acid. Eur J Clin Invest (2008) 1.52

Risk for renal failure in nephrolithiasis. Am J Kidney Dis (2001) 1.50

Oligomeric structure of the Bacillus subtilis cell division protein DivIVA determined by transmission electron microscopy. Mol Microbiol (2004) 1.45

Anticoagulant and aspirin prophylaxis for preventing thromboembolism after major gynaecological surgery. Cochrane Database Syst Rev (2003) 1.44

Ancient asymmetries in the evolution of flowers. Curr Biol (2001) 1.44

Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in the antiphospholipid-antibody syndrome. Haematologica (1999) 1.43

Road transportation affects blood hormone levels and lymphocyte glucocorticoid and beta-adrenergic receptor concentrations in calves. Vet J (2004) 1.43

Is the red cell morphology really useful to detect the source of hematuria? Am J Nephrol (1997) 1.39

Fimbriata controls flower development by mediating between meristem and organ identity genes. Cell (1994) 1.35

Quantification of power Doppler energy and its future potential. Fertil Steril (2001) 1.35

Plasma levels of endothelial cell protein C receptor are elevated in patients with sepsis and systemic lupus erythematosus: lack of correlation with thrombomodulin suggests involvement of different pathological processes. Blood (1998) 1.35

Control of flower development and phyllotaxy by meristem identity genes in antirrhinum. Plant Cell (1995) 1.34

Angiotensin-converting enzyme gene deletion polymorphism determines an increase in frequency of migraine attacks in patients suffering from migraine without aura. Eur Neurol (2000) 1.34

Springcleaning ribosomal DNA: a model for multigene evolution? Nature (1981) 1.32

Medullary sponge kidney (Lenarduzzi-Cacchi-Ricci disease): a Padua Medical School discovery in the 1930s. Kidney Int (2006) 1.24

Matrix metalloproteinase-2 and -9 levels in obese patients. Endothelium (2008) 1.23

Determination of 3H-norepinephrine and its metabolites in superfusate from isolated blood vessels. Arch Int Pharmacodyn Ther (1977) 1.23

Exenatide versus glibenclamide in patients with diabetes. Diabetes Technol Ther (2010) 1.21

Transthyretin fibrillogenesis entails the assembly of monomers: a molecular model for in vitro assembled transthyretin amyloid-like fibrils. J Mol Biol (2002) 1.18

Evaluation of metalloproteinase 2 and 9 levels and their inhibitors in diabetic and healthy subjects. Diabetes Metab (2007) 1.17

The induction and maintenance of flowering in Impatiens. Development (1997) 1.16

Manufactured shoes in the prevention of diabetic foot ulcers. Diabetes Care (1995) 1.16

Relation between lupus anticoagulant and splanchnic venous thrombosis in cirrhosis of the liver. BMJ (1994) 1.15

Platelets and the vessel wall: how much aspirin? Lancet (1980) 1.09

Amplification and overexpression of PRUNE in human sarcomas and breast carcinomas-a possible mechanism for altering the nm23-H1 activity. Oncogene (2001) 1.09

Monoclonal antibody-based enzyme-linked immunosorbent assays (ELISA) for the measurement of vitamin K-dependent protein S: the effect of antibody immunoreactivity on plasma protein S antigen determinations. Thromb Haemost (1992) 1.08

Chronic renal failure, end-stage renal disease, and peritoneal dialysis in Gitelman's syndrome. Am J Kidney Dis (2001) 1.07

A comparison of the safety and efficacy of oral anticoagulation for the treatment of venous thromboembolic disease in patients with or without malignancy. Thromb Haemost (2000) 1.03

High curative resection rate with weekly cisplatin, 5-fluorouracil, epidoxorubicin, 6S-leucovorin, glutathione, and filgastrim in patients with locally advanced, unresectable gastric cancer: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD). Br J Cancer (2004) 1.02

Mineral metabolism and bone mineral content in rheumatoid arthritis. Effect of corticosteroids. Clin Exp Rheumatol (1985) 1.02

Fatal cases of lipid storage myopathy with carnitine deficiency. J Neurol Neurosurg Psychiatry (1977) 1.01

Relationship between protein C antigen and anticoagulant activity during oral anticoagulation and in selected disease states. J Clin Invest (1986) 0.99

Bone density and skeletal metabolism are altered in idiopathic hypercalciuria. Clin Nephrol (1998) 0.98

Elevated total plasma homocysteine and 677C-->T mutation of the 5,10-methylenetetrahydrofolate reductase gene in thrombotic vascular disease. Am J Hum Genet (1996) 0.98

Pathways for inflorescence and floral induction in Antirrhinum. Development (1996) 0.98

Acute effects of moderate dietary protein restriction in patients with idiopathic hypercalciuria and calcium nephrolithiasis. Am J Clin Nutr (1999) 0.97

Effects of one-year cyclical treatment with clodronate on postmenopausal bone loss. Bone (1993) 0.97

Levels of polychlorinated biphenyls and organochlorine pesticides in some edible marine organisms from the Central Adriatic Sea. Chemosphere (2004) 0.97

Effects of 1-year orlistat treatment compared to placebo on insulin resistance parameters in patients with type 2 diabetes. J Clin Pharm Ther (2011) 0.96

Limits on light-speed anisotropies from Compton scattering of high-energy electrons. Phys Rev Lett (2010) 0.96

Activation of coagulation and fibrinolysis during coronary surgery: on-pump versus off-pump techniques. Anesthesiology (2001) 0.96

Effects of one year treatment of vildagliptin added to pioglitazone or glimepiride in poorly controlled type 2 diabetic patients. Horm Metab Res (2010) 0.95

In search of adult renal stem cells. J Cell Mol Med (2004) 0.94

Hyperhomocysteinaemia and poor vitamin B status in chronic obstructive pulmonary disease. Nutr Metab Cardiovasc Dis (2009) 0.93

Protein S deficiency occurs in the nephrotic syndrome. Ann Intern Med (1987) 0.93

Smad3 loss confers resistance to the development of trinitrobenzene sulfonic acid-induced colorectal fibrosis. Eur J Clin Invest (2009) 0.93

Possible link between vitamin D and hyperoxaluria in patients with renal stone disease. Clin Sci (Lond) (1993) 0.93

Modes and rates of change of complex DNA families of Drosophila. J Mol Biol (1982) 0.93

High-performance liquid chromatographic method for measuring total plasma homocysteine levels. J Chromatogr B Biomed Sci Appl (1998) 0.92

Perioperative management of four anaemic female Jehovah's Witnesses undergoing urgent complex cardiac surgery. Br J Anaesth (2007) 0.92

Lipoprotein(a) plasma concentrations, apolipoprotein (a) polymorphism and family history of coronary heart disease in patients with essential hypertension. J Cardiovasc Risk (1996) 0.91

Decreased plasma levels of soluble receptor for advanced glycation end products in mild cognitive impairment. J Neural Transm (Vienna) (2008) 0.91

Oral anticoagulation treatment in the elderly: a nested, prospective, case-control study. Arch Intern Med (2000) 0.90

Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with metformin. Intern Med J (2007) 0.90

A case of branchial cyst with an ectopic thyroid papillary carcinoma. Ann Ital Chir (2004) 0.90

Renal acidification defects in patients with recurrent calcium nephrolithiasis. Nephron (1985) 0.89

Metabolic effects of telmisartan and irbesartan in type 2 diabetic patients with metabolic syndrome treated with rosiglitazone. J Clin Pharm Ther (2007) 0.89

Change in major amputation rate in a center dedicated to diabetic foot care during the 1980s: prognostic determinants for major amputation. J Diabetes Complications (1998) 0.89

Fibrinogen Milano II: a congenital dysfibrinogenaemia associated with juvenile arterial and venous thrombosis. Thromb Haemost (1986) 0.89

Predictive value of plasma thrombomodulin in preeclampsia and gestational hypertension. Thromb Haemost (1998) 0.89

Chlorpropamide-alcohol flushing in non insulin-dependent diabetes: prevalence of small and large vessel disease and or risk factors for angiopathy. Acta Diabetol Lat (1982) 0.89

Potential failure of the International Normalized Ratio (INR) System in the monitoring of oral anticoagulation in patients with lupus anticoagulants. Ann Med Interne (Paris) (1996) 0.89

Hypercoagulability and high lipoprotein(a) levels in patients with central retinal vein occlusion. Thromb Haemost (1994) 0.88

Effects of kidney-pancreas transplantation on atherosclerotic risk factors and endothelial function in patients with uremia and type 1 diabetes. Diabetes (2001) 0.88

Alendronate prevents further bone loss in renal transplant recipients. J Bone Miner Res (2001) 0.88

Phosphorylation of nm23-H1 by CKI induces its complex formation with h-prune and promotes cell motility. Oncogene (2007) 0.87

Relationship between homocysteine and thrombotic disease. Am J Med Sci (1998) 0.87

Vertebral fractures in dialysis: Endocrinological disruption of the bone-kidney axis. J Endocrinol Invest (2010) 0.87

Quantitation of TGF-beta1 mRNA in porcine mesangial cells by comparative kinetic RT/PCR: comparison with ribonuclease protection assay and in situ hybridization. J Clin Lab Anal (2001) 0.87

IgA anti-actin antibodies ELISA in coeliac disease: a multicentre study. Dig Liver Dis (2007) 0.87

Increased urinary NO2-/NO3- and cyclic guanosine monophosphate levels in patients with Bartter's syndrome: relationship to vascular reactivity. Am J Kidney Dis (1996) 0.87

Transcription pattern of a FIM homologue in Impatiens during floral development and reversion. Plant J (1998) 0.87

Hypercoagulability in acute stroke: prognostic significance. Neurology (1987) 0.87

Behavioural and biochemical effects in the adult rat after prolonged postnatal administration of clozapine. Psychopharmacology (Berl) (1983) 0.87

Fetal inguinoscrotal hernia: prenatal ultrasound diagnosis and pathogenetic evaluation. Ultrasound Obstet Gynecol (1996) 0.86

Bone density and skeletal metabolism in patients with orthotopic ileal neobladder. J Am Soc Nephrol (1997) 0.86